You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary generalized tonic-clonic seizures

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Generalized Tonic-Clonic Seizures Trial (XEN1101, Placebo)

Not yet recruiting
  • Primary Generalized Tonic-Clonic Seizures
  • (no location specified)
Dec 27, 2022

Fycompa Tablets in Adolescence Epilepsy Partial-onset Seizures

Completed
  • Partial Seizures (With or Without Secondary Generalized Seizures)
  • Primary Generalized Tonic-clonic Seizures
  • Osaka, Japan
  • +1 more
Aug 3, 2022

Fycompa Tablets in Adult Epilepsy Partial-onset Seizures or

Completed
  • Partial Seizures (With or Without Secondary Generalized Seizures)
  • Primary Generalized Tonic-clonic Seizures
  • Osaka, Japan
  • +1 more
Feb 14, 2022

Partial Onset Seizures, Secondarily Generalized Seizures, Primary Generalized Tonic-Clonic Seizures Trial in United States

Completed
Has Results
  • Partial Onset Seizures
  • +2 more
  • Birmingham, Alabama
  • +23 more
Apr 21, 2022

Safety of Perampanel When Used as First Add-on Therapy in

Active, not recruiting
  • Idiopathic Generalized Epilepsy
  • +2 more
  • Esbjerg, South Denmark, Denmark
  • +35 more
Jan 10, 2023

Epilepsy, Idiopathic Generalized Epilepsy, Generalized Tonic Clonic Seizure Trial (Responsive stimulation, Sham stimulation)

Not yet recruiting
  • Epilepsy
  • +2 more
  • Responsive stimulation
  • Sham stimulation
  • (no location specified)
May 12, 2022

Partial-Onset or Primary Generalized Tonic-Clonic Seizures Trial in Worldwide (Perampanel)

Completed
Has Results
  • Partial-Onset or Primary Generalized Tonic-Clonic Seizures
  • Little Rock, Arkansas
  • +91 more
Jan 11, 2022

Perampanel as Only Add-on Treatment in Primary or Secondarily

Recruiting
  • Seizures
  • Aalen, Germany
  • +33 more
Dec 22, 2021

Epilepsy Trial in Worldwide (Lacosamide Tablet, Lacosamide Oral Solution)

Active, not recruiting
  • Epilepsy
  • Lacosamide Tablet
  • Lacosamide Oral Solution
  • Little Rock, Arkansas
  • +86 more
Jan 3, 2023

Severity: Quantifying Severity of Generalized Tonic-clonic

Recruiting
  • Epilepsy, Generalized
    • Lausanne, Switzerland
      Neurotech
    Jul 26, 2022

    Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy Trial in Worldwide (Cenobamate)

    Enrolling by invitation
    • Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy
    • La Jolla, California
    • +39 more
    May 23, 2022

    Epilepsy, Seizures Trial in Japan (Perampanel)

    Completed
    Has Results
    • Epilepsy
    • Seizures
    • Kurume, Fukuoka, Japan
    • +12 more
    Dec 9, 2020

    Epilepsy, Idiopathic Generalized Trial in Sari (Levetiracetam, Valproate)

    Completed
    Has Results
    • Epilepsy, Idiopathic Generalized
    • Sari, Mazandaran, Iran, Islamic Republic of
      Bu Ali Sina Hospital
    Dec 3, 2021

    Focal Epilepsy, Tonic-Clonic Seizures Trial (XEN1101)

    Not yet recruiting
    • Focal Epilepsy
    • Tonic-Clonic Seizures
    • (no location specified)
    Feb 7, 2023

    Primary Generalized Tonic-Clonic or Partial Onset Seizures, Lennox Gastaut Syndrome Trial in Worldwide (Perampanel)

    Available
    • Primary Generalized Tonic-Clonic or Partial Onset Seizures
    • Lennox Gastaut Syndrome
    • Brussels, Belgium
    • +21 more
    May 25, 2022

    Epilepsy Trial (Perampanel)

    Not yet recruiting
    • Epilepsy
    • (no location specified)
    Sep 6, 2022

    Epilepsy, Tonic-Clonic Trial in Lausanne (Embrace with Alert and Mate apps, Embrace with Mate app only)

    Terminated
    • Epilepsy, Tonic-Clonic
    • Embrace with Alert and Mate apps
    • Embrace with Mate app only
    • Lausanne, Switzerland
      Neurotech
    Jul 19, 2022

    CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm Trial in Atlanta, Memphis, Tacoma (ZX008

    Recruiting
    • CDKL5 Deficiency Disorder
    • +3 more
    • ZX008 (Fenfluramine Hydrochloride)
    • Matching ZX008 Placebo
    • Los Angeles, California
    • +16 more
    Jan 18, 2023

    Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures Trial in Worldwide (Pregabalin)

    Completed
    Has Results
    • Epilepsy, Partial Seizures
    • Epilepsy, Primary Generalized Tonic-Clonic Seizures
    • Tucson, Arizona
    • +150 more
    Jan 15, 2021

    Generalized Tonic Clonic Seizures Trial in Worldwide (Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo)

    Completed
    Has Results
    • Generalized Tonic Clonic Seizures
    • Pregabalin Dose Level 1
    • +2 more
    • Loxahatchee Groves, Florida
    • +126 more
    Jan 15, 2021

    Epilepsy Trial in Worldwide (Lacosamide Tablet, Lasosamide Oral Solution, Placebo Tablet)

    Completed
    Has Results
    • Epilepsy
    • Lacosamide Tablet
    • +3 more
    • Alabaster, Alabama
    • +114 more
    Nov 26, 2020

    Seizures, Lennox Gastaut Syndrome Trial in Bethesda, Hackensack (Carisbamate)

    Recruiting
    • Seizures
    • Lennox Gastaut Syndrome
    • Tampa, Florida
    • +13 more
    Feb 1, 2023

    Epilepsies, Partial, Epilepsy, Tonic-Clonic Trial in Belgium, United States (Microburst Stimulation)

    Active, not recruiting
    • Epilepsies, Partial
    • Epilepsy, Tonic-Clonic
    • Microburst Stimulation
    • Birmingham, Alabama
    • +8 more
    Dec 14, 2020

    Photosensitive Epilepsy Trial in Boston (Fenfluramine Hydrochloride)

    Active, not recruiting
    • Photosensitive Epilepsy
    • Fenfluramine Hydrochloride
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 16, 2022

    Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable Trial in United States (RNS System)

    Recruiting
    • Epilepsy
    • +4 more
    • RNS System
    • Birmingham, Alabama
    • +5 more
    Dec 28, 2022